ACAD compared with KOD: revenue, margins and what each company keeps, and the suppliers and customers both name

ACADAcadia Pharmaceuticals Inc

Mkt capRevenueRevenue

KODKodiak Sciences Inc.

Mkt capRevenueRevenue

Compare

ACADAcadia Pharmaceuticals Inc

KODKodiak Sciences Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only ACAD 4

STOKStoke Therapeuticssupplier

—Neurenunlistedsupplier

—Single wholesale distributorunlistedcustomer

—Third party distributorsunlistedcustomer

Shared 0

No shared counterparties.

Only KOD 1

—Lonzaunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

ACADAcadia Pharmaceuticals Inc

20.37▼−1.09%

Mkt cap$3.5BRevenue$308MQ2 FY26Revenue$1.1BFY25

KODKodiak Sciences Inc.

96.65▼−2.55%

Regular sessionNov 2 '26

Mkt cap$6.2BRevenue—Revenue—

Compare

Regular sessionNov 2 '26

ACADAcadia Pharmaceuticals Inc

KODKodiak Sciences Inc.

20.37▼−1.09%

Price

96.65▼−2.55%

$3.5B

Mkt cap

$6.2B

Q2 FY26$308M

Revenue

—

FY25$1.1B

Revenue

—

ACAD20.37▼−1.09%vsKOD96.65▼−2.55%Regular sessionNov 2 '26